U.S. Alzheimer's Disease Medication Markets


Regular Price: USD 4,950.00

Special Price USD 3,465.00

30% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,465.00


Be the first to review this product

The U.S. Alzheimer's disease medication markets research service provides revenue and patient forecasts, competitive analysis, market trends, product analysis and strategies for growth. The market is segmented by product type into cholinesterase inhibitors, NMDA receptor antagonists and new mechanism drugs. Each of the segments discusses in detail marketed products, revenue forecasts, product pipeline and competitive structure.

Table of Contents

U.S. Alzheimer's Disease Medication Markets, Executive SummaryExecutive SummaryIntroductionU.S. Alzheimer's Disease Medication Markets, Total Market IntroductionResearch Scope and SegmentationScope and SegmentationResearch MethodologyDisease Overview and Treatment OptionsDisease OverviewDisease ProgressionDisease Causes and Risk FactorsDisease BurdenDiagnosisTreatment OverviewTotal Market IntroductionIntroductionCompetitive StructureMarket Engineering MeasurementsUnmet Needs in the Alzheimer's Disease Medication MarketPatient ForecastsRevenue ForecastsMarket Share AnalysisGeneral Market TrendsIndustry ChallengesMarket DriversMarket RestraintsStrategies for GrowthStrategic RecommendationsU.S. Alzheimer's Disease Medication Markets, Cholinesterase Inhibitors MarketMarket OverviewIntroductionMarket Engineering MeasurementsProduct AnalysisFDA-approved ProductsPipeline AnalysisMarket ForecastsAricept ForecastExelon ForecastRazadyne ForecastCholinesterase Inhibitors MarketMarket Share AnalysisU.S. Alzheimer's Disease Medication Markets, NMDA Receptor Antagonists MarketMarket OverviewIntroductionMarket Engineering MeasurementsProduct AnalysisNamendaPipeline AnalysisMarket ForecastsNamenda ForecastU.S. Alzheimer's Disease Medication Markets, New Mechanism Products in DevelopmentOverviewIntroductionAmyloid Plaque Inhibitors Pipeline AnalysisSecretase Inhibitors Pipeline AnalysisImmunotherapeutics Pipeline AnalysisOther New Mechanism Drugs Pipeline AnalysisMarket ForecastsAlzhemed ForecastFlurizan ForecastU.S. Alzheimer's Disease Medication Markets, AppendixDecision Support DatabaseNumber of Alzheimer's PatientsAlzheimer's Disease DeathsTotal Healthcare ExpenditureMale Population 65 and AboveFemale Population 65 and Above

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.